Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial.

Taxonera C, López-Sanromán A, Vera-Mendoza I, Domènech E, Ruiz VV, Marín-Jiménez I, Guardiola J, Castro L, Esteve M, Iglesias E, Ceballos D, Martínez-Montiel P, Gisbert JP, Mínguez M, Echarri A, Calvet X, Barrio J, Hinojosa J, Martín-Arranz MD, Márquez-Mosquera L, Bermejo F, Rimola J, Alba C, Pons V, Nos P; Spanish GETECCU group (APPRECIA study).

Dig Liver Dis. 2019 Jan 14. pii: S1590-8658(19)30008-8. doi: 10.1016/j.dld.2019.01.002. [Epub ahead of print]

PMID:
30712954
2.

HIF-1α-regulated MIF activation and Nox2-dependent ROS generation promote Leishmania amazonensis killing by macrophages under hypoxia.

Alonso D, Serrano E, Bermejo FJ, Corral RS.

Cell Immunol. 2019 Jan;335:15-21. doi: 10.1016/j.cellimm.2018.10.007. Epub 2018 Oct 22.

PMID:
30384962
3.

Erratum to the article «Implementation and evaluation of early gastroscopy for patients with dyspepsia and warning signs in Primary Care».

García-Alonso FJ, Hernández Tejero M, Rubio Benito E, Valer P, Guerra I, García Ceballos VG, Noguerol M, Llinares V, Bermejo F.

Gastroenterol Hepatol. 2018 Nov;41(9):609-610. doi: 10.1016/j.gastrohep.2018.09.003. Epub 2018 Oct 14. English, Spanish. No abstract available.

PMID:
30327156
4.

Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.

Chaparro M, Garre A, Ricart E, Iborra M, Mesonero F, Vera I, Riestra S, García-Sánchez V, Luisa De Castro M, Martin-Cardona A, Aldeguer X, Mínguez M, de-Acosta MB, Rivero M, Muñoz F, Andreu M, Bargalló A, González-Muñoza C, Pérez Calle JL, García-Sepulcre MF, Bermejo F, Huguet JM, Cabriada JL, Gutiérrez A, Mañosa M, Villoria A, Carbajo AY, Lorente R, García-López S, Piqueras M, Hinojosa E, Arajol C, Sicilia B, Conesa AM, Sainz E, Almela P, Llaó J, Roncero O, Camo P, Taxonera C, Domselaar MV, Pajares R, Legido J, Madrigal R, Lucendo AJ, Alcaín G, Doménech E, Gisbert JP; GETECCU study group.

Aliment Pharmacol Ther. 2018 Oct;48(8):839-851. doi: 10.1111/apt.14930.

PMID:
30281832
5.

The impact of Dependency Act benefits on employment.

Bermejo F, Del Pozo-Rubio R.

Gac Sanit. 2018 Aug 23. pii: S0213-9111(18)30041-4. doi: 10.1016/j.gaceta.2017.12.007. [Epub ahead of print]

6.

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease.

Taxonera C, Ponferrada Á, Riestra S, Bermejo F, Saro C, Martín-Arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, López-Serrano P, Barrio J, Suarez C, Iglesias E, Argüelles-Arias F, Ferrer I, Marín-Jiménez I, Hernández-Camba A, Bastida G, Van Domselaar M, Martínez-Montiel P, Olivares D, Rivero M, Fernandez-Salazar L, Nantes Ó, Merino O, Alba C, Gisbert JP; CONVERT study group from GETECCU .

J Crohns Colitis. 2018 Nov 15;12(11):1270-1279. doi: 10.1093/ecco-jcc/jjy104.

PMID:
30052856
7.

A Green Soundscape Index (GSI): The potential of assessing the perceived balance between natural sound and traffic noise.

Kogan P, Arenas JP, Bermejo F, Hinalaf M, Turra B.

Sci Total Environ. 2018 Nov 15;642:463-472. doi: 10.1016/j.scitotenv.2018.06.023. Epub 2018 Jun 14.

PMID:
29908505
8.

Resources used in the treatment of perianal Crohn's disease and the results in a real-life cohort.

Rubín de Célix Vargas C, Algaba A, Guerra I, Serrano Á, Pérez-Viejo E, Aulló C, Bermejo F.

Gastroenterol Hepatol. 2018 Jun - Jul;41(6):353-361. doi: 10.1016/j.gastrohep.2018.04.006. Epub 2018 May 11. English, Spanish.

PMID:
29759924
9.

Histamine catabolism in Pseudomonas putida U: identification of the genes, catabolic enzymes and regulators.

de la Torre M, Gómez-Botrán JL, Olivera ER, Bermejo F, Rodríguez-Morán J, Luengo JM.

Environ Microbiol. 2018 May;20(5):1828-1841. doi: 10.1111/1462-2920.14118. Epub 2018 Apr 23.

PMID:
29614211
10.

Self-Formation Assessed by Cumulative Summation Test Does Not Reach Recommended Thresholds for Optical Diagnosis of Colorectal Polyps ≤ 7 mm.

García-Alonso FJ, Manzano Santamaría I, Guardiola Arévalo A, Pique Becerra R, Leandro Barros A, de Sande Rivera N, Moreno Casas G, Arribas Terradillos S, Llerena Riofrío Á, Escolano Peco CA, Alguacil Rodríguez E, Bermejo F.

Dig Dis Sci. 2018 Oct;63(10):2573-2581. doi: 10.1007/s10620-018-5008-5. Epub 2018 Mar 9.

PMID:
29524115
11.

Cultural and communicative memories: contrasting Argentina's 1976 coup d'état and the 2001 economic-political-social crisis.

Muller F, Bermejo F, Hirst W.

Memory. 2018 Aug;26(7):974-984. doi: 10.1080/09658211.2018.1431283. Epub 2018 Jan 31.

PMID:
29385911
12.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.

Bermejo F, Aguas M, Chaparro M, Domènech E, Echarri A, García-Planella E, Guerra I, Gisbert JP, López-Sanromán A; en representación de GETECCU.

Gastroenterol Hepatol. 2018 Mar;41(3):205-221. doi: 10.1016/j.gastrohep.2017.11.007. Epub 2018 Jan 19. Review. English, Spanish.

PMID:
29357999
13.

Glassy Anomalies in the Low-Temperature Thermal Properties of a Minimally Disordered Crystalline Solid.

Gebbia JF, Ramos MA, Szewczyk D, Jezowski A, Krivchikov AI, Horbatenko YV, Guidi T, Bermejo FJ, Tamarit JL.

Phys Rev Lett. 2017 Nov 24;119(21):215506. doi: 10.1103/PhysRevLett.119.215506. Epub 2017 Nov 21.

PMID:
29219416
14.

Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.

Garcia-Planella E, Mañosa M, Chaparro M, Beltrán B, Barreiro-de-Acosta M, Gordillo J, Ricart E, Bermejo F, García-Sánchez V, Piqueras M, Llaó J, Gisbert JP, Cabré E, Domènech E; PRECUCAL study group Investigators.

Scand J Gastroenterol. 2018 Feb;53(2):152-157. doi: 10.1080/00365521.2017.1410219. Epub 2017 Nov 30.

PMID:
29189092
15.

Pharmacological Approach to the Management of Crohn's Disease Patients with Perianal Disease.

Bermejo F, Guerra I, Algaba A, López-Sanromán A.

Drugs. 2018 Jan;78(1):1-18. doi: 10.1007/s40265-017-0842-x. Review.

PMID:
29139091
16.

Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.

Linares PM, Algaba A, Urzainqui A, Guijarro-Rojas M, González-Tajuelo R, Garrido J, Chaparro M, Gisbert JP, Bermejo F, Guerra I, Castellano V, Fernández-Contreras ME.

Dig Dis Sci. 2017 Oct;62(10):2744-2754. doi: 10.1007/s10620-017-4717-5. Epub 2017 Aug 19.

PMID:
28823012
17.

Prevalence, risk factors and response to treatment of extra-intestinal manifestations in patients with inflammatory bowel disease.

Hernández-Tejero M, Granja Navacerrada A, Bernal Checa P, Piqué Becerra R, Algaba García A, Guerra Marina I, García-Alonso FJ, Syed M, Bermejo F.

Rev Esp Enferm Dig. 2017 Sep;109(9):627-633. doi: 10.17235/reed.2017.4845/2017.

18.

Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.

Ordás I, Domènech E, Mañosa M, García-Sánchez V, Iglesias-Flores E, Peñalva M, Cañas-Ventura A, Merino O, Fernández-Bañares F, Gomollón F, Vera M, Gutiérrez A, Garcia-Planella E, Chaparro M, Aguas M, Gento E, Muñoz F, Aguirresarobe M, Muñoz C, Fernández L, Calvet X, Jiménez CE, Montoro MA, Mir A, De Castro ML, García-Sepulcre MF, Bermejo F, Panés J, Esteve M.

Am J Gastroenterol. 2017 Nov;112(11):1709-1718. doi: 10.1038/ajg.2017.180. Epub 2017 Jul 4.

PMID:
28675163
19.

Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.

Valer P, Algaba A, Santos D, Fuentes ME, Nieto E, Gisbert JP, López P, Quintanilla E, García-Alonso FJ, Guerra I, Páez Á, Bermejo F.

Inflamm Bowel Dis. 2017 Jul;23(7):1144-1153. doi: 10.1097/MIB.0000000000001081.

PMID:
28520588
20.

Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial.

López-Sanromán A, Vera-Mendoza I, Domènech E, Taxonera C, Vega Ruiz V, Marín-Jiménez I, Guardiola J, Castro L, Esteve M, Iglesias E, Ceballos D, Martínez-Montiel P, Gisbert JP, Mínguez M, Echarri A, Calvet X, Barrio J, Hinojosa J, Martín-Arranz MD, Márquez-Mosquera L, Bermejo F, Rimola J, Pons V, Nos P; Spanish GETECCU group [APPRECIA study].

J Crohns Colitis. 2017 Oct 27;11(11):1293-1301. doi: 10.1093/ecco-jcc/jjx051.

PMID:
28402454
21.

Thermodynamic and Kinetic Fragility of Freon 113: The Most Fragile Plastic Crystal.

Vispa A, Romanini M, Ramos MA, Pardo LC, Bermejo FJ, Hassaine M, Krivchikov AI, Taylor JW, Tamarit JL.

Phys Rev Lett. 2017 Mar 10;118(10):105701. doi: 10.1103/PhysRevLett.118.105701. Epub 2017 Mar 7.

PMID:
28339247
22.

Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease.

Taxonera C, Ponferrada Á, Bermejo F, Riestra S, Saro C, Martín-Arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, López-Serrano P, Barrio J, Suarez C, Iglesias E, Argüelles-Arias F, Ferrer I, Marín-Jiménez I, Hernández-Camba A, Bastida G, Van Domselaar M, Martínez-Montiel P, Olivares D, Alba C, Gisbert JP; SEGURTB study group from GETECCU.

J Crohns Colitis. 2017 Jul 1;11(7):792-800. doi: 10.1093/ecco-jcc/jjx022.

PMID:
28333182
23.

Erratum to "IV Spanish Consensus Conference on Helicobacter pylori infection treatment" <[Gastroenterol Hepatol 39 (2016) 697-721]>.

Gisbert JP, Molina-Infante J, Amador J, Bermejo F, Bujanda L, Calvet X, Castro-Fernández M, Cuadrado-Lavín A, Elizalde JI, Gene E, Gomollón F, Lanas Á, de Argila CM, Mearin F, Montoro M, Pérez-Aisa Á, Pérez-Trallero E, McNicholl AG.

Gastroenterol Hepatol. 2017 May;40(5):378. doi: 10.1016/j.gastrohep.2017.02.004. Epub 2017 Mar 11. English, Spanish. No abstract available.

PMID:
28291549
24.

Implanted muon spin spectroscopy on 2-O-adamantane: a model system that mimics the liquid[Formula: see text]glasslike transitions.

Romanini M, Tamarit JL, Pardo LC, Bermejo FJ, Fernandez-Perea R, Pratt FL.

J Phys Condens Matter. 2017 Mar 1;29(8):085405. doi: 10.1088/1361-648X/aa530d. Epub 2017 Jan 17.

PMID:
28095369
25.

Knowledge acquired, satisfaction attained and attitudes towards shared decision making in colorectal cancer screening.

Garcia-Alonso FJ, Tejero MH, Cambrodón DB, Bermejo F.

Ann Gastroenterol. 2017;30(1):76-82. doi: 10.20524/aog.2016.0090. Epub 2016 Sep 30.

26.

What is the real-life maintenance mesalazine dose in ulcerative colitis?

Algaba A, Guerra I, García García de Paredes A, Hernández Tejero M, Ferre C, Bonillo D, Aguilera L, López-Sanromán A, Bermejo F.

Rev Esp Enferm Dig. 2017 Feb;109(2):114-121. doi: 10.17235/reed.2016.4620/2016.

27.

Implementation and evaluation of early gastroscopy for patients with dyspepsia and warning signs in Primary Care.

García-Alonso FJ, Hernández Tejero M, Rubio Benito E, Valer P, Guerra I, García Ceballos VG, Noguerol M, Llinares V, Bermejo F.

Gastroenterol Hepatol. 2017 May;40(5):331-338. doi: 10.1016/j.gastrohep.2016.10.004. Epub 2016 Dec 20. English, Spanish. Erratum in: Gastroenterol Hepatol. 2018 Nov;41(9):609-610.

PMID:
28010892
28.

Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.

Taxonera C, Iglesias E, Muñoz F, Calvo M, Barreiro-de Acosta M, Busquets D, Calvet X, Rodríguez A, Pajares R, Gisbert JP, López-Serrano P, Pérez-Calle JL, Ponferrada Á, De la Coba C, Bermejo F, Chaparro M, Olivares D, Alba C, Fernández-Blanco I.

Dig Dis Sci. 2017 Feb;62(2):481-490. doi: 10.1007/s10620-016-4398-5. Epub 2016 Dec 19.

PMID:
27995400
29.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.

Casanova MJ, Chaparro M, García-Sánchez V, Nantes O, Leo E, Rojas-Feria M, Jauregui-Amezaga A, García-López S, Huguet JM, Arguelles-Arias F, Aicart M, Marín-Jiménez I, Gómez-García M, Muñoz F, Esteve M, Bujanda L, Cortés X, Tosca J, Pineda JR, Mañosa M, Llaó J, Guardiola J, Pérez-Martínez I, Muñoz C, González-Lama Y, Hinojosa J, Vázquez JM, Martinez-Montiel MP, Rodríguez GE, Pajares R, García-Sepulcre MF, Hernández-Martínez A, Pérez-Calle JL, Beltrán B, Busquets D, Ramos L, Bermejo F, Barrio J, Barreiro-de Acosta M, Roncedo O, Calvet X, Hervías D, Gomollón F, Domínguez-Antonaya M, Alcaín G, Sicilia B, Dueñas C, Gutiérrez A, Lorente-Poyatos R, Domínguez M, Khorrami S, Muñoz C, Taxonera C, Rodríguez-Pérez A, Ponferrada A, Van Domselaar M, Arias-Rivera ML, Merino O, Castro E, Marrero JM, Martín-Arranz M, Botella B, Fernández-Salazar L, Monfort D, Opio V, García-Herola A, Menacho M, Ramírez-de la Piscina P, Ceballos D, Almela P, Navarro-Llavat M, Robles-Alonso V, Vega-López AB, Moraleja I, Novella MT, Castaño-Milla C, Sánchez-Torres A, Benítez JM, Rodríguez C, Castro L, Garrido E, Domènech E, García-Planella E, Gisbert JP.

Am J Gastroenterol. 2017 Jan;112(1):120-131. doi: 10.1038/ajg.2016.569. Epub 2016 Dec 13.

PMID:
27958281
30.

Response to Letter to the Editor.

Duart-Clemente JM, Álvarez-Galovich L, Bermejo FT, Piñera-Parrilla Á, Mengis-Palleck C, Albisua-Sánchez J, Duart-Clemente JV.

Spine (Phila Pa 1976). 2016 Dec 1;41(23):E1432-E1433. No abstract available.

PMID:
27893651
31.

Acceptance, yield and feasibility of attaching HCV birth cohort screening to colorectal cancer screening in Spain.

García-Alonso FJ, Bonillo-Cambrodón D, Bermejo A, García-Martínez J, Hernández-Tejero M, Valer López Fando P, Piqueras B, Bermejo F.

Dig Liver Dis. 2016 Oct;48(10):1237-42. doi: 10.1016/j.dld.2016.06.034. Epub 2016 Jul 11.

PMID:
27481585
32.

IV Spanish Consensus Conference on Helicobacter pylori infection treatment.

Gisbert JP, Molina-Infante J, Amador J, Bermejo F, Bujanda L, Calvet X, Castro-Fernández M, Cuadrado-Lavín A, Elizalde JI, Gene E, Gomollón F, Lanas Á, Martín de Argila C, Mearin F, Montoro M, Pérez-Aisa Á, Pérez-Trallero E, McNicholl AG.

Gastroenterol Hepatol. 2016 Dec;39(10):697-721. doi: 10.1016/j.gastrohep.2016.05.003. Epub 2016 Jun 21. English, Spanish. Erratum in: Gastroenterol Hepatol. 2017 May;40(5):378.

PMID:
27342080
33.

Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.

R-Grau Mdel C, Chaparro M, Mesonero F, Barreiro-de Acosta M, Castro L, Castro M, Domènech E, Mancenido N, Pérez-Calle JL, Taxonera C, Barrio J, De Francisco R, Fernández-Salgado E, Luzón L, Merino O, Oltra L, Saro C, Bermejo F, García-Sánchez V, Ginard D, Gutiérrez A, Vera I, Antón R, Ber Y, Calvet X, Gisbert JP.

Dig Liver Dis. 2016 Jun;48(6):613-9. doi: 10.1016/j.dld.2016.02.012. Epub 2016 Mar 2.

PMID:
26992847
34.

Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.

Guerra I, Pérez-Jeldres T, Iborra M, Algaba A, Monfort D, Calvet X, Chaparro M, Mañosa M, Hinojosa E, Minguez M, Ortiz de Zarate J, Márquez L, Prieto V, García-Sánchez V, Guardiola J, Rodriguez GE, Martín-Arranz MD, García-Tercero I, Sicilia B, Masedo Á, Lorente R, Rivero M, Fernández-Salazar L, Gutiérrez A, Van Domselaar M, López-SanRomán A, Ber Y, García-Sepulcre M, Ramos L, Bermejo F, Gisbert JP; Spanish GETECCU group (ENEIDA project).

Inflamm Bowel Dis. 2016 Apr;22(4):894-901. doi: 10.1097/MIB.0000000000000757.

PMID:
26933750
35.

Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.

Taxonera C, Barreiro-de-Acosta M, Bastida G, Martinez-Gonzalez J, Merino O, García-Sánchez V, Gisbert JP, Marín-Jiménez I, López-Serrano P, Gómez-García M, Iglesias E, Lopez-Sanroman A, Chaparro M, Saro C, Bermejo F, Pérez-Carazo L, Plaza R, Olivares D, Alba C, Mendoza JL, Fernández-Blanco I.

J Crohns Colitis. 2016 Jun;10(6):657-62. doi: 10.1093/ecco-jcc/jjw016. Epub 2016 Jan 19.

PMID:
26786982
36.

A one-stop clinic in gastroenterology - Benefits and limitations.

Bermejo F.

Rev Esp Enferm Dig. 2016 Jan;108(1):1-2.

37.

Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's disease.

Chaparro M, Barreiro-de Acosta M, García-Planella E, Domènech E, Bermejo F, Calvet X, Martín Arranz MD, Monfort D, Gisbert JP.

Gastroenterol Hepatol. 2016 Apr;39(4):255-60. doi: 10.1016/j.gastrohep.2015.06.007. Epub 2015 Nov 24.

PMID:
26620278
38.

Effect of Chondroitin Sulphate on Pro-Inflammatory Mediators and Disease Activity in Patients with Inflammatory Bowel Disease.

Linares PM, Chaparro M, Algaba A, Román M, Moreno Arza I, Abad Santos F, Ochoa D, Guerra I, Bermejo F, Gisbert JP.

Digestion. 2015;92(4):203-10. doi: 10.1159/000439522. Epub 2015 Sep 19.

PMID:
26381879
39.

Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile.

Medrano LM, Taxonera C, González-Artacho C, Pascual V, Gómez-García M, Barreiro-de Acosta M, Pérez-Calle JL, Bermejo F, López-Sanromán A, Martín Arranz D, Gisbert JP, Mendoza JL, Martín J, Núñez C, Urcelay E.

Mediators Inflamm. 2015;2015:318207. doi: 10.1155/2015/318207. Epub 2015 Aug 3.

40.

Thermal properties of halogen-ethane glassy crystals: Effects of orientational disorder and the role of internal molecular degrees of freedom.

Vdovichenko GA, Krivchikov AI, Korolyuk OA, Tamarit JL, Pardo LC, Rovira-Esteva M, Bermejo FJ, Hassaine M, Ramos MA.

J Chem Phys. 2015 Aug 28;143(8):084510. doi: 10.1063/1.4929530.

PMID:
26328859
41.

Argentines' collective memories of the military Junta of 1976: differences and similarities across generations and ideology.

Muller F, Bermejo F, Hirst W.

Memory. 2016 Aug;24(7):990-1006. doi: 10.1080/09658211.2015.1061013. Epub 2015 Aug 21.

PMID:
26293779
42.

[Biological drugs in inflammatory bowel disease: Management and care].

Guerra I, Bermejo F.

Rev Esp Enferm Dig. 2015 Jul;107(7):454. Spanish. No abstract available.

43.

Sensorimotor strategies for recognizing geometrical shapes: a comparative study with different sensory substitution devices.

Bermejo F, Di Paolo EA, Hüg MX, Arias C.

Front Psychol. 2015 Jun 9;6:679. doi: 10.3389/fpsyg.2015.00679. eCollection 2015.

44.

Glassy Dynamics versus Thermodynamics: The Case of 2-Adamantanone.

Szewczyk D, Jeżowski A, Vdovichenko GA, Krivchikov AI, Bermejo FJ, Tamarit JL, Pardo LC, Taylor JW.

J Phys Chem B. 2015 Jul 2;119(26):8468-74. doi: 10.1021/acs.jpcb.5b04240. Epub 2015 Jun 24.

PMID:
26073682
45.

Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.

Taxonera C, Barreiro-de Acosta M, Calvo M, Saro C, Bastida G, Martín-Arranz MD, Gisbert JP, García-Sánchez V, Marín-Jiménez I, Bermejo F, Chaparro M, Ponferrada Á, Martínez-Montiel MP, Pajares R, de Gracia C, Olivares D, Alba C, Mendoza JL, Fernández-Blanco I.

Dig Dis Sci. 2015 Oct;60(10):3075-84. doi: 10.1007/s10620-015-3735-4. Epub 2015 Jun 5.

PMID:
26044830
46.

[Biosimilars in inflamatory bowel disease: Management and care].

Guerra I, Bermejo F.

Rev Esp Enferm Dig. 2015 Jun;107(6):389. Spanish. No abstract available.

47.

Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study.

Molina-Infante J, Lucendo AJ, Angueira T, Rodriguez-Tellez M, Perez-Aisa A, Balboa A, Barrio J, Martin-Noguerol E, Gomez-Rodriguez BJ, Botargues-Bote JM, Gomez-Camarero J, Huerta A, Modolell I, Ariño I, Herranz-Bachiller MT, Bermejo F, McNicholl AG, O'Morain C, Gisbert JP; European Registry on H. pylori management (Hp‐EuReg).

Aliment Pharmacol Ther. 2015 Mar;41(6):581-9. doi: 10.1111/apt.13069. Epub 2015 Jan 14.

48.

Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.

Gisbert JP, Romano M, Gravina AG, Solís-Muñoz P, Bermejo F, Molina-Infante J, Castro-Fernández M, Ortuño J, Lucendo AJ, Herranz M, Modolell I, Del Castillo F, Gómez J, Barrio J, Velayos B, Gómez B, Domínguez JL, Miranda A, Martorano M, Algaba A, Pabón M, Angueira T, Fernández-Salazar L, Federico A, Marín AC, McNicholl AG.

Aliment Pharmacol Ther. 2015 Apr;41(8):768-75. doi: 10.1111/apt.13128. Epub 2015 Feb 23.

49.

Incidence, management, and course of cancer in patients with inflammatory bowel disease.

Algaba A, Guerra I, Marín-Jiménez I, Quintanilla E, López-Serrano P, García-Sánchez MC, Casis B, Taxonera C, Moral I, Chaparro M, Martín-Rodríguez D, Martín-Arranz MD, Manceñido N, Menchén L, López-Sanromán A, Castaño Á, Bermejo F.

J Crohns Colitis. 2015 Apr;9(4):326-33. doi: 10.1093/ecco-jcc/jjv032. Epub 2015 Feb 16.

PMID:
25687203
50.

Gallstone-related disease in the elderly: is there room for improvement?

García-Alonso FJ, de Lucas Gallego M, Bonillo Cambrodón D, Algaba A, de la Poza G, Martín-Mateos RM, Bermejo F.

Dig Dis Sci. 2015 Jun;60(6):1770-7. doi: 10.1007/s10620-014-3497-4. Epub 2015 Jan 11.

PMID:
25577265

Supplemental Content

Loading ...
Support Center